The company said, “For the fiscal year ending December 31, 2025, the Company now expects total revenue to grow 20% to $734 million compared to the previous expectation of $732 million. This includes surgical revenue of $658 million and EOS revenue of $76 million. The Company now expects non-GAAP adjusted EBITDA of approximately $78 million compared to the previous expectation of $75 million.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC:
- Is ATEC a Buy, Before Earnings?
- Unusually active option classes on open April 15th
- Alphatec Holdings: Strategic Growth and Resilience Amid Economic Pressures with a Buy Rating
- Alphatec Holdings Implements Executive Salary Conversion Plan
- Alphatec Holdings: Strong Growth Potential and Undervalued Buy Opportunity
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue